Introduction
Immortalization is one of the necessary, multiple steps of tumorigenesis. Normal mammalian somatic cells can only divide a limited number of times in vitro. The maximum number of divisions is called the 'Hayflick limit' (Hayflick, 1976) . This nonproliferative state is also referred to as replicative cellular senescence. Typical characteristics of senescing cells include a large, flat morphology, a high frequency of nuclear abnormalities, and positive staining for b-galactosidase activity specifically at pH 6.0. The counting mechanism for the intrinsic replicative lifespan appears to be the shortening of telomeres with each cell division cycle (Huschtscha and Holliday, 1983) . The phenotype of senescence is a dominant trait, and the genes associated with it fall into four complementation groups (Pereira- Smith and Smith, 1983) .
Human cells can be immortalized through the transduction of viral and cellular oncogenes (Graham et al., 1977; Huschtscha and Holliday, 1983) , various human oncogenes such as c-myc (Gutman and Wasylyk, 1991) , or in some rare cases spontaneously Rogan et al., 1995; Shay et al., 1995) . These mechanisms of immortalization result in abrogation of p53 and pRB/p16 ink4a -mediated terminal proliferation arrest and the activation of a telomere maintenance mechanism (Rogan et al., 1995; Duncan et al., 2000) . The activation of human telomerase reverse transcriptase (hTERT) expression is one of the telomere maintenance mechanisms that allow cells to bypass senescence. Certain immortalized human cell lines and some tumors (Bryan et al., 1997) maintain their telomeres in the absence of detectable telomerase activity by a mechanism, referred to as alternative lengthening of telomeres (ALT) , that may involve telomere-telomere recombination (Dunham et al., 2000) .
Senescence can also be induced in immortal cells by a DNA methyltransferase (DNMT) inhibitor, 5-aza-2 0 -deoxycytidine (5AZA-dC) (Vogt et al., 1998) , implying that replicative senescence can result from epigenetic changes in gene expression (Herman and Baylin, 2000; Newell-Price et al., 2000; Baylin et al., 2001) . Genes regulated by DNA methylation usually contain upstream regulatory regions and immediate downstream sequences enriched in CpG dinucleotides (CpG islands). Cytidine residues within CpG islands are methylated by DNMT that can recruit histone deacetylases resulting in the formation of condensed chromatin structures containing hypoacetylated histones. Hypomethylation of CpG islands in oncogenes and hypermethylation of tumor-suppressor genes are important regulatory mechanisms in tumor initiation and progression of cancer (Vogt et al., 1998; Baylin et al., 2001 ).
Li-Fraumeni syndrome (LFS) is a familial cancer syndrome that is characterized by multiple primary tumors including soft-tissue sarcomas, osteosarcomas, breast carcinomas, brain tumors, leukemias, adrenalcortical carcinomas, to a lesser extent melanoma and carcinomas of the lung, pancreas, and prostate. Heterozygous germline p53 mutations were found in 75% of families having LFS (Malkin et al., 1990; Malkin, 1994) . Fibroblast cell lines established from individuals with LFS develop changes in morphology, chromosomal abnormalities, and spontaneously form immortal cell lines (Hayflick, 1976; Bischoff et al., 1990; Malkin et al., 1990) . Vogt et al. (1998) demonstrated that the treatment of immortal LFS fibroblasts with 5AZA-dC results in arrest of growth of the fibroblasts and development of a senescent phenotype. We report here that repression of gene expression because of methylation-dependent silencing occurs upon cellular immortalization and a significant proportion of these genes are regulated in the interferon (IFN) pathway. Silencing of this growth-suppressive pathway may be an important early event in the development of cancer, specifically associated with immortalization.
Results

Changes in gene expression after immortalization
We employed preimmortal (PD 11) and immortal (PD 212) fibroblast cells (MDAH041 cell line) from an LFS patient to analyse the changes in gene expression during cellular immortalization. We isolated total RNA from these cells and probes were synthesized for hybridization to microarrays, Affymetrix HGU95Av2 GeneChips. The genes were selected using two different methods: (i) the classical method of selecting the genes with at least a predetermined fold change and (ii) an ANOVAbased noise sampling selection method (Draghici, 2002) . All the four possible pairings between preimmortal vs immortal cell gene expression comparisons were performed using independent cellular RNAs prepared from these cells. The fold change method was used to select the genes with twofold or greater change in gene expression. There were 169 upregulated and 450 downregulated genes satisfying this condition (Table 1) . The noise-sampling selection method is based on ANOVA (Kerr et al., 2000) and uses replicate measurements to estimate an empirical distribution of the noise. Given this distribution and a chosen confidence level, one can establish which genes are differentially regulated beyond the influence of the noise. This method identified 76 upregulated and 217 downregulated genes.
The two methods are in some sense complementary. The noise-sampling method selects those genes that have reproducible changes higher than the noise threshold at some confidence level, whereas the N-fold method selects those genes that have a minimal fold change that can be confirmed with other assays such as quantitative real time PCR (Q-RT-PCR). The intersection of the subsets of genes reported as differentially regulated by both methods identified 59 upregulated genes and 192 downregulated genes after immortalization (Table 1) . Using a representative set of the genes satisfying both conditions (for both downregulated and upregulated genes), the microarray data were confirmed using Q-RT-PCR (Table 2) . Comparison of the levels of gene expression after immortalization obtained by using both microarray hybridization and Q-RT-PCR revealed outstanding accuracy of the data. Since Q-RT-PCR data can cover a larger range of expression levels, the data obtained using microarrays and Q-RT-PCR differed quantitatively.
Effect of 5AZA-dC gene expression in immortal LFS fibroblasts
As was first shown by Fairweather et al. (1987) , in vitro lifespan of normal human fibroblasts could be shortened by exposure of the cells to the demethylating agent 5AZA-dC. In agreement with this, Vogt et al. (1998) have shown that treatment of LFS immortal fibroblasts with 5AZA-dC results in growth arrest and senescence. Thus, there is a possibility that development of immortalization is related to methylation-induced silencing of gene expression. To address this issue, the immortal cells (MDAH041 high passage cell culture) were treated with 5AZA-dC to induce gene demethylation. Treated MDAH041 cells had flat morphology, contained lipofuscin granules, and showed senescence-associated bgalactosidase activity at pH 6 (data not shown), typical for the senescent cells (Dimri et al., 1995) . Total RNA was prepared from MDAH041, highpassage (HP) treated or untreated with 5AZA-dC, and used to prepare probes for the microarray hybridizations. Affymetrix HGU95Av2 GeneChips were again used and the data were analysed as described above for the comparison of preimmortal and immortal MDAH041 cells. The comparison of treated and untreated HP cells identified 48 5AZA-dC upregulated and 190 5AZA-dC downregulated genes with at least a twofold change and 150 upregulated and 328 downregulated genes selected by ANOVA (Table 1 ). There were 81 upregulated genes and only one downregulated gene that satisfied both conditions (Poa and fold change42) ( Table 1) . A sampling of genes covering a range of gene expression changes was chosen and confirmed using Q-RT-PCR (Table 3) .
We next determined whether changes in gene expression using Q-RT-PCR after 5AZA-dC treatment were specific to cells undergoing senescence by comparing gene expression changes induced by 5AZA-dC treatment in normal mortal human fibroblasts with those in the immortal MDAH041 cells. The expression levels of 15 of these genes were analysed in preimmortal lowpassage (LP) MDAH041 and normal mortal fibroblast cells (CRL-1502) untreated or treated with 5AZA-dC using Q-RT-PCR (Table 4 ). The vast majority of the 5AZA-dC-dependent changes in expression found in the immortal MDAH041 cells were not induced by 5AZA-dC treatment of the normal human fibroblasts or preimmortal MDAH041 LFS fibroblasts. The exception, IFNa-inducible protein, p27, is found in a known imprinted region on chromosome 14q32 and its induction by 5AZA-dC in all cells therefore was not surprising. In summary, while treatment with 5AZA-dC strongly induces expression of many genes silenced in immortal cells, the expression levels of the same genes were not significantly affected by 5AZA-dC treatment of mortal fibroblasts.
Genes downregulated after immortalization and silenced by gene methylation
Since 5AZA-dC-induced gene expression results in the reversal of immortal phenotype and the induction of a senescent-like state, we investigated whether inhibition of DNMT by 5AZA-dC upregulates genes repressed after immortalization. Table 5 shows the list of 85 genes selected by either or both selection methods as silenced Tumor necrosis factor-inducible (TSG-6) À5.2 10.3 N after immortalization due to methylation. Interestingly, when the 'reverse' identification of genes was attempted (i.e. genes, both upregulated after immortalization but repressed by 5AZA-dC), no common genes were identified using the dual selection method approach (Table 1 , comparison of A and C). In view of the fact that the numbers of genes identified in these comparisons (comparisons B and D (85 genes), and A and C (three genes)) were so vastly different, these suggested that methylation-dependent gene silencing is mechanistically significant to the process of immortalization. Microarray analysis of MDAH041 cells containing a tetracycline-modulated p53 gene revealed that none of these 85 genes were regulated by p53 in these cells (data not shown). Analysis of the functional annotations of the genes downregulated in immortalization (Table 5) , because of methylation-dependent silencing, revealed that a significant fraction, 39 out of 85 genes, are known to be regulated by the IFN pathway, with 19 of the 39 genes containing CpG islands identified using CpGPlot software (Table 6 ).
Hierarchical clustering
The hierarchical map of the silenced gene expression set and two subsets of genes (identified by both software methods) that are repressed after immortalization by methylation-dependent silencing is shown in Figures  1a,b . In these figures, the height of each bridge between members of a cluster is proportional to the average squared distance of each leaf in the subtree from that subtree's centroid (or mean). These data indicate that the level of expression of the same set of genes that are downregulated during immortalization is also stimulated by 5AZA-dC-induced DNA demethylation. Interestingly, the approach showed that the total pattern of gene expression (12 558 genes) in preimmortal MDAH041 cells is similar to the 5AZA-dC-treated immortal MDAH041 cells as compared to the untreated immortal cells (data not shown). In Figure 1a , the set of 85 genes silenced by methylation show a pattern of low expression in the immortal fibroblasts (indicated by the green color) and higher expression in the preimmortal MDAH041 cells and in the 5AZA-dC-treated immortal cells (indicated by the red color). Figure 1b similarly shows the pattern of gene expression in the group of 30 genes selected by 99.99% confidence and 4twofold change in expression.
Discussion
The indefinite lifespan necessary for the formation of a cancer cell appears to be a complex genetic trait with four complementation groups of recessive genes (Pereira- Smith, 1983, 1988; Berube et al., 1998) . Since treatment of spontaneously immortalized LiFraumeni cells, MDAH041, with the DNMT inhibitor, 5AZA-dC, results in a replicative senescent state (Baylin et al., 2001) , epigenetic control of immortalization needed to be considered in these cells. We employed Affymetrix microarrays to profile gene expression changes associated with immortalization and determined which of those genes were also regulated by DNA demethylation. We hypothesized that genes downregulated after immortalization (493 genes) would fit the pattern of recessive senescence genes predicted by the somatic cell genetics experiments (Pereira- Smith and Smith, 1988) . Consistent with this hypothesis, we reasoned that those in common with the 190 genes upregulated after the 5AZA-dC treatment would focus the gene set on those involved in replicative senescence. This gene set included a total of 85 genes from those available on the microarrays used. One of these genes is known to be maternally imprinted in the Prader-Willi The fold changes for genes with multiple probe set ID's were averaged Table 5 ). The protein encoded by this gene, Necdin, is a growth suppressor expressed in postmitotic neurons of the brain (Nakada et al., 1998) . We found that this RNA is silenced during immortalization and activated by 5AZA-dC treatment of the immortal MDAH041 cells but not normal fibroblasts or preimmortal MDAH041 (Table 4) . Interestingly, this gene was found to undergo loss of heterozygosity in the MDAH041 immortal cells (data not shown). We observed downregulation in immortal MDAH041 cells of some genes (collagenase, cathepsin O, uPA) (data not shown) that have been detected by others as upregulated genes during replicative senescence in dermal fibroblasts (Shelton et al., 1999) . We also observed downregulation of DOC1, IGFBP4 and IGFBP6 in immortal cells (data not shown) that is correlated with the published data before of Schwarze Remarkably, 39 of these 85 genes were also known to be regulated in the IFN pathway and represent candidate regulatory genes in cellular immortalization. These data are in agreement with others who observed 5AZA-dC upregulation of IFN pathway genes in colon tumor cells (Karpf et al., 1999) and human bladder cancer cells (Liang et al., 2002) . To calculate the significance of this observation, we used the UniGene clusters in order to eliminate overcounting genes with several accession numbers and/or Affymetrix probes. Currently, the 12 558 probes on the array correspond to 8628 Unigene clusters. Among these, there are 137 genes, or 0.015%, known to be IFN-regulated. Thus, we expect that a list of 85 random genes will contain about 85 Â 0.015% or approximately zero IFN-regulated À47 which shows that the silencing of the IFN-pathway genes is highly significant to the mechanism of cellular immortalization. Figure 1 Hierarchical clustering of gene expression. Gene expression in MDAH041 fibroblast culture, LP (preimmortal), HP (immortal) and HP treated with 5AZA-dC (5AZA) was analysed. The graph includes only those genes whose expression was decreased during transition from preimmortal to immortal cell state, and was upregulated to the high level after treatment with 5AZA-dC. Each row represents a gene and each column represents an independent microarray experiment of different RNA preparations. (a) 85 genes reported by either analysis methods: twofold and ANOVA; (b) 30 genes reported by both twofold and ANOVA methods Some IFN-regulated genes have previously been shown to be silenced by DNA methylation and reactivated by 5AZA-dC treatment (Liang et al., 2002) . Consistent with this observation and the growth-inhibitory effect of IFNs, 5AZA-dC treatment has been shown to inhibit the growth of human tumor cell lines (Bender et al., 1998) and our data indicate that gene silencing may be an early event in cancer development. The IFN-regulated RNaseL gene is known to inhibit cell proliferation and induce apoptosis through the IFN-regulated (2 0 -5 0 ) oligoadenylate synthetase pathway. RNaseL is a candidate tumor-suppressor gene that has been shown to be mutated in the germ line of hereditary prostate cancer patients (Carpten et al., 2002) . This candidate tumor-suppressor gene, RNaseL, is activated by (2 0 -5 0 ) oligoadenylate synthetase proteins and therefore it is noteworthy that in MDAH041 cells, three out of four of the isoforms of the (2 0 -5 0 ) oligoadenylate synthetase are downregulated after immortalization because of methylation-dependent silencing (Table 6 ). In addition, IRF-1 has been shown to be a tumor-suppressor gene in human leukemias Willman et al., 1993) . The double-stranded RNA-activated protein kinase (PKR) has been shown to induce apoptosis, implying that its inactivation would be a procarcinogenic event (Jagus et al., 1999) . The IFNinducible proteins of the 'HIN-200 gene family' have been demonstrated to be growth inhibitory, have antitumor activity (Wen et al., 2001; Xin et al., 2001) , and are able to bind to the Rb1 and p53 tumorsuppressor proteins (Choubey and Lengyel, 1995) . We found that one of the three members of this gene family, AIM2, is downregulated in MDAH041 cells and silenced by methylation (Table 6 ). AIM2 functions as a tumor suppressor for a melanoma cell line (DeYoung et al., 1997) and a T-cell tumor antigen in neuroectodermal tumors, as well as breast, ovarian, and colon carcinomas (Harada et al., 2001) . The AIM2 gene contains a site of microsatellite instability (MSI) that results in gene inactivation in 47% of colorectal tumors analysed with high MSI (Mori et al., 2001) . Interestingly, p202, a member of the murine '200 gene family', is a negative regulator of p53 whose gene expression is controlled by p53 as well .
MDAH041 LFS cells contain significant telomerase activity after immortalization (Gollahon et al., 1998) . Although in microarray analysis, the hTERT gene for the protein of enzymatic subunit of telomerase was not significantly upregulated after immortalization of MDAH041 cells, 1.6-fold, we found using Q-RT-PCR that there was a significant increase in hTERT expression, 486-fold (Table 2) . This is consistent with our experience that genes with low basal expression levels are difficult to quantitate accurately using microarrays alone. We found that 5AZA-dC treatment resulted in an additional 17-fold increase in hTERT RNA expression (Table 3) . Interestingly, the promoter of the hTERT gene has been shown to be regulated by methylation at CpG islands (Dessain et al., 2000; Bechter et al., 2002) . Using CpGPlot, we performed an analysis for the presence of CpG islands in the 39 interferon-regulated genes that we identified. In all, 19 of those genes contained CpG islands (Table 6) . We expect that a subset of these 19 genes represents the primary inducers of cellular senescence and/or aging. p16 INK4a is one of the tumor-suppressor genes whose expression is repressed by methylation, which permits cells to bypass early mortality check points. In our study, we confirmed downregulation of p16 mRNA in immortal cells and upregulation by demethylation using RT-PCR (data not shown). When we tested the level of protein expression using Western blots, we found that TGGTGAGGGTCAGAAACCATTC  MIF  CCCGCAGGGTCTACATCAA  CGCAGACAGCGTGGGTC  CYP1B1  GGCAGAATTGGATCAGGTCG  AGCGCATGGCTTCATAAAGG  SNF2A  CATGCTTCTCTGTCACAACGC  TCTGCCGGGCACTCTTAAAC  MRP3  GGGTCCTTGTCCCTCCTTTC  TCCGATGCTCAGCCACCTAT  CD24  GAGAATCTACCCCAGATCCAAGC  GCTCTTGTTGAATGGAAACAGGT  MGSA  CAACCCCAAGTTAGTTCAATCTGG  TGTTGCAGGCTCCTCAGAAAT  WISP  AGACAGGGAAAGGTCAGCCC  AAGGAAGAGCCTGGCCAACT  Dermatopontin  TCCAGAGCCGCTACTTCGAG  TTCTGTTGTTAGCCAGCAGGAA  p78  GCCACTGGACTGACGACTTGA  ACTGCTCTCACAGCTTCCTGC  GSTA4  ACCAGATGATCAGCAAAAGGAAG  AGCTTTGTCCGTGACCCCT  IRF7  GCAGCGTGAGGGTGTGTCTT  GCTCCATAAGGAAGCACTCGAT  CIG49  CTTGCCAAACAGATGTCCTCC  TGTGGATTCCAACACCCGTT Vogt et al. (1998) , who demonstrated that retroviral transduction of a p16
INK4a cDNA was able to induce senescence in MDAH041 cells. Although retroviral transduction of a p21 cDNA was also able to induce senescence in MDAH041 cells (Vogt et al., 1998) , p21 protein levels were not regulated by 5AZA-dC treatment of immortal MDAH041 (data not shown) cells. It is noteworthy that p21 cip/waf was also identified as sdi1 because of its high levels of expression in senescing mortal fibroblasts (Noda et al., 1994) and is regulated transcriptionally by DNMT (Young and Smith, 2001) . p21 can also be regulated by STAT1 which is also a major transcriptional effector of the IFN pathway (Agrawal et al., 2002) . The level of STAT1 protein is two-fold downregulated after immortalization and 4.7-fold upregulated in immortal cells by 5AZA-dC treatment (data not shown). Therefore, STAT1 is silenced by methylation in immortal MDAH041 cells (Tables 5 and 6 ) and may be a key regulator of immortalization by controlling the interferon-regulated gene expression pathway and its growth-suppressive effectors. As these mechanisms become better understood, specific demethylation or deacetylation agents currently in preclinical evaluation and clinical trials in cancer patients will provide another approach to control cancer (Brown and Strathdee, 2002) .
Materials and methods
Cell culture and p53 genotypin
The MDAH041 (p53 frameshift mutation) cell line was derived from primary fibroblasts obtained by skin biopsy from patients with LFS. Characterization and immortalization of these cells was performed by Bischoff et al. (1990) . All cells were grown in modified Eagles medium (MEM, Gibco BRL, MD, USA) with 10% fetal calf serum and antibiotics. The CRL1502 cell line was derived from primary fibroblasts obtained by skin biopsy from a normal donor (ATCC 1502, Rockville, MD, USA). The region containing the frameshift mutation in gene encoding p53 from LP preimmortal and HP immortal cells was sequenced to confirm the heterozygosity in LP preimmortal MDAH041 cells.
Treatment of cells with 5AZA-dC
Fibroblast cell cultures were seeded 3 Â 10 5 per plate in MEM medium with 10% fetal calf serum and antibiotics. Cell cultures were treated with 1 mm 5AZA-dC on days 1, 3, and 5 each time with a full media change. After day 6, the cells were returned to regular medium without 5AZA-dC. Total RNA preparation was performed on day 8.
RNA isolation and the Affymetrix microarray assays
The cells were grown to 80% confluence, the medium was changed, and after 16 h the cells were washed with PBS, trypsinized, and pelleted at 300 g for 5 min. Total RNA was isolated using RNeasy kit (Qiagen Inc., Valencia, CA, USA). 1.5 Â 10 7 cells yielded B200 mg total RNA. The RNA targets (biotin-labeled RNA fragments) were synthesized from 5 mg of total RNA by first synthesizing double-stranded cDNA followed by standard Affymetrix protocols (Affymetrix, Santa Clara, CA, USA).
Quantization of gene expression by Q-RT-PCR
Total RNA (1 mg) was reverse transcribed into cDNA using Superscript II (Life Technologies, Gaithersburg, MD, USA). All methods for reactions were performed as recommended by the manufacturer. The ABI 5700 Sequence Detection System was used for Q-RT-PCR. The protocols and analysis of data are identical to that of the ABI 7700 Sequence Detection System (ABISYBR). All methods for reactions and quantitation were performed as recommended by the manufacturer. An extensive explanation and derivation of the calculations involved can be found in the ABI User Bulletin x2 and also in the manual accompanying the SYBR Green PCR core kit. Primers used in Q-RT-PCR are shown in Table 7 .
Analysis of microarray data
Microarray experiments were performed using the Affymetrix HG-U95A chip containing 12 558 probes. Two RNA preparations from immortal cells (HP) were compared with two RNA preparations from preimmortal cells (LP). In addition, two RNA preparations from immortal cells (HP) were compared with three total RNA preparations from immortal cells treated with 5AZA-dC using the HG-U95A chips.
Two analysis methods were used to select differentially regulated genes: fold change and noise sampling method (ANOVA). The fold change method was used to select the genes with at least a twofold change in expression. This was done using the Affymetrix Data Mining Tool (DMT), version 3, N-fold method (Affymetrix, Santa Clara, CA, USA). For the control vs experiment comparisons, all possible pairings between the two controls and the two experiments were considered.
The noise sampling method is a variation of the ANOVA model proposed by Kerr and Churchill (Kerr et al., 2000; Draghici, 2002) . The noise sampling method was implemented in GeneSight, version 3.2.21 (Biodiscovery, Los Angeles, CA, USA). In order to apply the noise sampling method, the intensities, obtained from each chip, were normalized by dividing by the mean intensity. Four ratios were formed by taking all possible combinations of experiments and controls. We looked for genes differentially regulated with a 99.99% confidence (Po0.0001).
CpG island analysis
First, we retrieved the genome sequence of each IFN-regulated RNA from UCSD Genome Browser (http://genome.ucsc.edu/). Then we tested the CpG islands within an interval of À500 to þ 200 bp around the transcription starting site (TSS) using CpGPlot program (http://www.ebi.ac.uk/emboss/cpgplot/). The discrimination for CpG islands is based on the formal definition of CpG islands (Gardiner-Garden and Frommer, 1987) (length is over 200 bp, G þ C content is greater than 50%, statistical expectation is greater than 0.6).
